Cited by 28

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease

Bzhilyanskaya, Vera, Ma, Linyuan, Liu, Siyuan, Fox, Lauren R., Whittaker, Madelynn N., Meis, Ronald J., Choi, Uimook, Lawson, Amanda, Ma, Michelle, Theobald, Narda, Burkett, Sandra, Sweeney, Colin L., Lazzarotto, Cicera R., Tsai, Shengdar Q., Lack, Justin B., Wu, Xiaolin, Dahl, Gary A., Malech, Harry L., Kleinstiver, Benjamin P., De Ravin, Suk See·2024·Science Translational Medicine

Abstract

X-linked chronic granulomatous disease (X-CGD) is an inborn error of immunity (IEI) resulting from genetic mutations in the cytochrome b-245 beta chain ( CYBB ) gene. The applicability of base editors (BEs) to correct mutations that cause X-CGD is constrained by the requirement of Cas enzymes to recognize specific protospacer adjacent motifs (PAMs). Our recently engineered PAMless Cas enzyme, SpRY, can overcome the PAM limitation. However, the efficiency, specificity, and applicability of SpRY-based BEs to correct mutations in human hematopoietic stem and progenitor cells (HSPCs) have not been thoroughly examined. Here, we demonstrated that the adenine BE ABE8e-SpRY can access a range of target sites in HSPCs to correct mutations causative of X-CGD. For the prototypical X-CGD mutation CYBB c.676C>T, ABE8e-SpRY achieved up to 70% correction, reaching efficiencies greater than three-and-one-half times higher than previous CRISPR nuclease and donor template approaches. We profiled potential off-target DNA edits, transcriptome-wide RNA edits, and chromosomal perturbations in base-edited HSPCs, which together revealed minimal off-target or bystander edits. Edited alleles persisted after transplantation of the base-edited HSPCs into immunodeficient mice. Together, these investigational new drug–enabling studies demonstrated efficient and precise correction of an X-CGD mutation with PAMless BEs, supporting a first-in-human clinical trial (NCT06325709) and providing a potential blueprint for treatment of other IEI mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.adj6779

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 69

  1. 10.1126/scitranslmed.aad8856 · DOI · Paper page
  2. 10.1038/s41591-019-0735-5 · DOI · Paper page
  3. 10.1016/j.jaci.2019.03.012 · DOI
  4. 10.1016/S2352-3026(19)30021-3 · DOI
  5. 10.1038/s41467-022-31344-x · DOI · Paper page
  6. 10.1038/3233 · DOI
  7. 10.1038/sj.cgt.7700232 · DOI
  8. 10.1038/s41591-020-0790-y · DOI
  9. 10.1038/s41588-023-01434-7 · DOI
  10. 10.1056/NEJMoa2300709 · DOI
  11. 10.1097/00005792-200005000-00003 · DOI · Paper page
  12. 10.1093/cid/ciu1154 · DOI
  13. 10.1542/peds.114.2.462 · DOI
  14. 10.1038/s41588-021-00838-7 · DOI · Paper page
  15. 10.1038/s41556-019-0425-z · DOI
  16. 10.1038/nbt.4317 · DOI
  17. 10.1038/s41588-020-0623-4 · DOI · Paper page
  18. 10.1038/nbt.4192 · DOI · Paper page
  19. 10.1038/ncomms15178 · DOI
  20. 10.1038/nature24644 · DOI · Paper page
  21. 10.1038/nbt.3803 · DOI · Paper page
  22. 10.1038/nature17946 · DOI · Paper page
  23. 10.1038/s41596-021-00525-1 · DOI
  24. 10.1038/s41573-020-0084-6 · DOI
  25. 10.1126/science.1225829 · DOI · Paper page
  26. 10.1038/nbt.2508 · DOI · Paper page
  27. 10.1038/s41477-020-00827-4 · DOI
  28. 10.1111/pbi.13838 · DOI · Paper page
  29. 10.1038/s41467-022-30228-4 · DOI
  30. 10.1038/s41467-022-31034-8 · DOI
  31. 10.1038/nature16526 · DOI · Paper page
  32. 10.1038/s41587-019-0254-4 · DOI
  33. 10.1016/j.tig.2021.09.002 · DOI
  34. 10.1038/s41587-020-0412-8 · DOI
  35. 10.1007/978-1-0716-2879-9_5 · DOI
  36. 10.1182/blood.2021011192 · DOI
  37. 10.1182/blood.2020008503 · DOI
  38. 10.3389/fgeed.2022.923718 · DOI
  39. 10.1016/j.bbmt.2020.09.031 · DOI
  40. 10.1038/nbt.3290 · DOI · Paper page
  41. 10.1016/j.stem.2010.06.014 · DOI · Paper page
  42. 10.1182/blood.V77.6.1218.1218 · DOI
  43. 10.1084/jem.172.1.363 · DOI
  44. 10.1038/bcj.2011.35 · DOI
  45. 10.1038/s41587-020-0555-7 · DOI
  46. 10.14797/mdcj-10-1-3 · DOI
  47. 10.1038/s41587-024-02142-1 · DOI
  48. 10.1126/scitranslmed.aan0820 · DOI · Paper page
  49. 10.1038/nbt.4172 · DOI · Paper page
  50. 10.1517/14712598.8.6.725 · DOI
  51. 10.1007/s00294-021-01211-1 · DOI
  52. 10.1126/sciadv.aax5717 · DOI
  53. 10.3389/fimmu.2022.1067417 · DOI
  54. 10.1038/s41587-020-0491-6 · DOI
  55. 10.1038/s41587-023-01915-4 · DOI · Paper page
  56. 10.1038/s41586-019-1711-4 · DOI · Paper page
  57. 10.1038/s41576-022-00541-1 · DOI
  58. 10.1038/s41587-023-01947-w · DOI
  59. 10.1038/s41587-024-02324-x · DOI
  60. 10.1038/s41587-019-0032-3 · DOI
  61. 10.1038/s41587-020-0562-8 · DOI
  62. 10.1038/s41587-022-01492-y · DOI
  63. 10.1101/gr.275579.121 · DOI
  64. 10.1038/s41592-018-0051-x · DOI
  65. 10.1186/s13059-016-1029-6 · DOI
  66. 10.1101/861054 · DOI
  67. 10.1038/s41525-021-00227-3 · DOI
  68. 10.1016/0888-7543(92)90147-K · DOI
  69. 10.1002/gcc.2870040311 · DOI

Cited by

See all 28

Metadata

Authors
Bzhilyanskaya, V., Ma, L., Liu, S., Fox, L. R., Whittaker, M. N., Meis, R. J., Choi, U., Lawson, A., Ma, M., Theobald, N., Burkett, S., Sweeney, C. L., Lazzarotto, C. R., Tsai, S. Q., Lack, J. B., Wu, X., Dahl, G. A., Malech, H. L., Kleinstiver, B. P., & De Ravin, S. S.
Affiliations
  • Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Molecular Cytogenetic Core Facility, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
  • CELLSCRIPT, Madison, WI 53713, USA.
  • Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA.
  • Bioinformatics (NCBR)/Integrated Data Sciences Section (IDSS), Research Technology Branch/DIR/NIAID, Frederick, MD 21702, USA.
Venue
Science Translational Medicine
Published
2024-10-16
Volume
16
Issue
769
ISSN
  • 1946-6234
  • 1946-6242
Cited by
28
References
14
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease. https://app.cochat.ai/papers/10.1126/scitranslmed.adj6779
The paper
Bzhilyanskaya, V., Ma, L., Liu, S., Fox, L. R., Whittaker, M. N., Meis, R. J., Choi, U., Lawson, A., Ma, M., Theobald, N., Burkett, S., Sweeney, C. L., Lazzarotto, C. R., Tsai, S. Q., Lack, J. B., Wu, X., Dahl, G. A., Malech, H. L., Kleinstiver, B. P., & De Ravin, S. S. (2024). High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adj6779